Autolus Therapeutics plc
AUTL
$1.60
$0.021.27%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -90.33M | -79.12M | -47.92M | -70.16M | -27.61M |
| Total Depreciation and Amortization | 2.63M | 2.54M | 2.37M | 2.28M | 2.08M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 19.40M | 21.03M | -4.31M | 10.02M | -9.42M |
| Change in Net Operating Assets | 983.00K | -12.35M | -22.92M | -17.70M | -2.99M |
| Cash from Operations | -67.32M | -67.90M | -72.78M | -75.57M | -37.93M |
| Capital Expenditure | 885.00K | -4.41M | -7.28M | -8.24M | -11.11M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 85.66M | 39.96M | 103.19M | -51.30M | -372.48M |
| Cash from Investing | 86.54M | 35.55M | 95.92M | -59.55M | -383.59M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | 7.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1.80M | -1.77M | -768.00K | -- | 30.00M |
| Cash from Financing | -1.80M | -1.77M | -768.00K | -- | 30.01M |
| Foreign Exchange rate Adjustments | 589.00K | -3.58M | 5.72M | 3.56M | -38.22M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 18.01M | -37.71M | 28.08M | -131.55M | -429.73M |